-
Plasma-Centric Drugmaker Grifols To Buy Geriatric Pharma Startup Alkahest
Tuesday, September 8, 2020 - 2:17am | 352Blood plasma and diagnostics company Grifols SA (NASDAQ: GRFS) is set to completely acquire Alkahest Inc, a biopharmaceutical startup focussed on neurodegenerative and age-related diseases, for $146 million on a debt-free basis. What Happened: Grifols will buy the remaining equity in Alkahest...